Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

»õ·Î¿î Ç÷°ü½Å»ýÀÎÀÚÀÎ À̽¶¸°-À¯»ç ¼ºÀåÀÎÀÚ II (IGF-II)ÀÇ Àü»çÁ¶Àý¿¡ °üÇÑ ¿¬±¸ Regulation of Transcriptional Activity of Insulin-like Growth Factor II (IGF-II)

´ëÇѾϿ¹¹æÇÐȸÁö 2002³â 7±Ç 1È£ p.27 ~ 33
¹è¸íÈ£, ¼ÛÇö¼®, ¹è¼ö°æ, À̼®±â, À̼¼¿ø, ±èö¿ì, ±è±Ô¿ø,
¼Ò¼Ó »ó¼¼Á¤º¸
¹è¸íÈ£ ( Bae Myung-Ho ) 
ºÎ»ê´ëÇб³ ºÐÀÚ»ý¹°Çаú

¼ÛÇö¼® ( Song Hyun-Seok ) 
ºÎ»ê´ëÇб³ ºÐÀÚ»ý¹°Çаú
¹è¼ö°æ ( Bae Soo-Kyung ) 
ºÎ»ê´ëÇб³ ºÐÀÚ»ý¹°Çаú
À̼®±â ( Lee Seok-Ki ) 
¼­¿ï´ëÇб³ ¾àÇдëÇÐ
À̼¼¿ø ( Lee Sae-Won ) 
¼­¿ï´ëÇб³ ¾àÇдëÇÐ
±èö¿ì ( Kim Chul-Woo ) 
¼­¿ï´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç
±è±Ô¿ø ( Kim Kyu-Won ) 
¼­¿ï´ëÇб³ ¾àÇдëÇÐ

Abstract


It has been known that IGF-II is required for normal pre-natal growth of the liver in rodents and humans and has an angiogenic effect in experimental animals. The human IGF-II gene is a complex transcription unit containing four different promoters, leading to the formation of multiple IGF-II mRNA. The four promoters can be activated in a development-dependent and tissue-dependent manner. The human IGF-II promoter P3 is used in many fetal tissues and is highly active in several tumors, suggesting autocrine effects of IGF-II in tumor progression. In this study, we confirmed increased transcriptional activity of IGF-II P3 promoter under hypoxia. In addition, we showed that MAPK pathway is not involved in activation mechanism of IGF-II P3 promoter by using MAPK nhibitors and JNK dominant negative mutants. Moreover, we investigated the effect of hypoxia on the transcriptional activity of Egr-l, possible transcription factor regu1ating IGF-II. These results may examine the molecular signaling mechanism of carcinogenesis and metastasis in hepatocellular carcinoma and can apply to the development of cancer diagnosis and therapy.

Å°¿öµå

Insulin like Growth Factor-I;; Mitogen activated protein kinase;Transcriptional activity; Hypoxia

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

 

µîÀçÀú³Î Á¤º¸